10-K
XBRL
FORM 10-K
- Company
- Anixa Biosciences Inc
- Filed
- January 30, 2012
- Period of Report
- October 31, 2011
- Accession Number
- 0001193125-12-029810
A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →